PHS
TSRO

PFM Health Sciences’s TESARO, Inc. TSRO Stock Holding History

PFM Health Sciences’s Portfolio TSRO Stock Details TSRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-221,100
Closed -$29.7M – 130
2016
Q4 		$29.7M Buy
+221,100
New +$27.9M 0.84% 43

Other funds holding TSRO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences's TSRO Position: Q3 2013 in Review

PFM Health Sciences sold out of TESARO, Inc. (TSRO) in Q3 2013, closing a stake of 502,438 shares — an estimated $16.4M sold.

PFM Health Sciences first reported a position in TSRO in Q2 2013 and held it in 1 quarter. The position peaked at $16.4M in Q2 2013. 93 funds tracked by Wall St. Rank hold TSRO as of Q3 2013.

  • PFM Health Sciences reported no remaining TESARO, Inc. position as of Q3 2013 after selling out during the quarter.
  • PFM Health Sciences sold 502,438 TESARO, Inc. shares in Q3 2013, an estimated $16.4M.
  • PFM Health Sciences first reported a position in TESARO, Inc. in Q2 2013 and held it in 1 quarter.
  • PFM Health Sciences's TESARO, Inc. position peaked at $16.4M in Q2 2013.
  • 93 funds tracked by Wall St. Rank held TESARO, Inc. as of Q3 2013.

Based on PFM Health Sciences's 13F filing for Q3 2013, filed 14 Nov 2013.